Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Anti Viral Drugs Companies

ID: MRFR/HC/1821-HCR
200 Pages
Satyendra Maurya
Last Updated: February 16, 2025
Anti-viral drugs are designed to treat viral infections by inhibiting the replication of viruses.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Anti Viral Drugs Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)4.76%
2024 Market Size$ 61.45 Billion
2025 Market Size$ 64.38 Billion
2035 Market Size$ 102.49 Billion

Key Players

Companies such as Gilead Sciences
 AbbVie
Merck & Co
GlaxoSmithKline
Bristol-Myers Squibb
AstraZeneca
Opportunities
  • Government Initiatives and Funding
  • Emergence of Drug-Resistant Viruses
  • Increasing Incidence of Viral Infections

Top Industry Leaders in the Anti Viral Drugs Market

Anti-viral drugs Key Companies
ย 
Latest Anti-viral drugs Companies Update

Pfizer's Paxlovid transition to commercial distribution: November 2023, Pfizer's oral COVID-19 treatment Paxlovid transitioned from government-managed distribution to traditional commercial channels. This move aims to improve patient access and availability beyond government supply.

Gilead Sciences receives FDA approval for Sunvepra for cytomegalovirus (CMV) infections: September 2023, Gilead Sciences received FDA approval for Sunvepra (ciluprevvir/ganciclovir) for the treatment of CMV infections in adult hematopoietic stem cell transplant recipients.

Roche secures positive Phase 3 trial results for Actemra/RoActemra combination in preventing CMV disease: October 2023, Roche announced positive results from a Phase 3 trial evaluating the combination of Actemra/RoActemra (tocilizumab) with standard-of-care anti-viral therapy for preventing CMV disease in adult kidney transplant recipients.

List of Anti-viral drugs Key Companies in the Market

  • Johnson & Johnson
  • Merck & Co. Inc.
  • Gilead Sciences Inc.
  • Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Abbott Laboratories
  • Novartis International AG
  • Astra Zeneca AB
  • Cipla Inc.